A new report from Magellan subsidiary iCore provides information on trends in specialty drugs covered under a plan's medical benefit, indicating that these compounds' use and cost continues to rise…
Read More
Our penultimate Potpourri delivers the quality you are accustomed to (for good or bad), including presents of health information on the Medicare physician payment method, telemonitoring results in the UK,…
Read More
The holiday shopping season is in full swing but our Potpourri is free, filled with useful data on high-deductible health plans and utilization, Medicare Advantage plan Stars bonuses, drug complications…
Read More
Pricing for drugs is an arcane world. The Office of Inspector General has attempted to shed light on pricing benchmarks and methodologies and in a new report tries to provide…
Read More
A new paper at the National Bureau of Economic Research examines the relationship between technology and spending growth in health care. While no firm conclusions are reached, a country's willingness…
Read More
Drug manufacturers have a new trick up their sleeve to get consumers to use their expensive branded products instead of cheaper alternatives--copay coupon programs. These programs significantly raise spending with…
Read More
Winter nears but our Potpourri will distract you from the cold breezes, providing compelling nuggets on prostate screening recommendations, consumer use of technology for health, insurer medical cost trends, what…
Read More